| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 462 |
| 1 | NIVOLUMAB | 266 |
| 2 | CARBOPLATIN | 213 |
| 3 | ATEZOLIZUMAB | 204 |
| 4 | PREDNISONE | 188 |
| 5 | OMEPRAZOLE MAGNESIUM | 185 |
| 6 | OMEPRAZOLE | 161 |
| 7 | ADALIMUMAB | 157 |
| 8 | IPILIMUMAB | 154 |
| 9 | PREDNISOLONE | 146 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 4 | 0.0377 |
| 1 | BUTALBITAL, ASPIRIN, CAFEINE, AND CODEINE PHOSPHATE | 1 | 0.0286 |
| 2 | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | 1 | 0.0189 |
| 3 | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0156 |
| 4 | CAPSICUM ANNUUM, FUCUS VESICULOSUS, BORAGE OFFICINALIS, LECITHIN, CALCAREA CARBONICA, FERRUM METALLICUM, KALI BICHROMICUM, KALI CARBONICA, PULSATILLA (PRATENSIS), SULPHUR | 1 | 0.0114 |
| 5 | PLATINUM | 6 | 0.0113 |
| 6 | NAFCILLIN SODIUM | 9 | 0.0098 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 56 | 0.0067 |
| 8 | AVELUMAB | 25 | 0.0061 |
| 9 | CEMIPLIMAB-RWLC | 12 | 0.0058 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 818 |
| 1 | Corticosteroid [EPC] | 449 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 300 |
| 3 | Platinum-based Drug [EPC] | 259 |
| 4 | Proton Pump Inhibitor [EPC] | 222 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 194 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 160 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 156 |
| 8 | Kinase Inhibitor [EPC] | 125 |
| 9 | Loop Diuretic [EPC] | 124 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 818 | 0.0083 |
| 1 | Type I Interferon Receptor Antagonist [EPC] | 9 | 0.0047 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 82 | 0.0038 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 160 | 0.0033 |
| 4 | Rifamycin Antimycobacterial [EPC] | 7 | 0.0020 |
| 5 | Macrolide Antibacterial [EPC] | 2 | 0.0020 |
| 6 | Selective T Cell Costimulation Blocker [EPC] | 9 | 0.0019 |
| 7 | Provitamin D2 Compound [EPC] | 55 | 0.0018 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 19 | 0.0015 |
| 9 | Chemokine Receptor Type 4 Interaction [EPC] | 2 | 0.0015 |